A novel enzymatic amperometric method is described for the determination of oxalic acid in urine. An amperometric biosensor was made by immobilizing oxalate oxidase on the surface of a chromium(III) hexacyanoferrate-modified graphite electrode by using a bovine serum albumin and glutaraldehyde cross-linking procedure. The enzyme biocatalyzes oxalate decomposition in the presence of oxygen into carbon dioxide and hydrogen peroxide. The oxalate concentration, which is proportional to the amount of hydrogen peroxide, was determined amperometrically by measuring the current resulting in the reduction of hydrogen peroxide at a very low working potential (0.05 V versus the Hg | Hg 2 Cl 2 | 3M KCl electrode), which minimized the influence of the possible interferences present in human urine. All experiments were performed with succinic buffer, pH 3.8, containing 0.1M KCl and 5.4mM ethylenediaminetetraacetic acid. In an aqueous solution of pure oxalic acid, the biosensor showed good linearity in a concentration range of 2.5-100mM without the use of a dialysis membrane. For untreated urine samples, a high correlation (R 2 = 0.9949) was obtained between oxalate concentrations added to urine samples and oxalate recoveries calculated for determinations with the described oxalate biosensor.
M easurement of oxalic acid in urine is of clinical interest in 2 groups of patients: those with calcium oxalate renal stones, and those with conditions in which increased excretion of oxalate is known to occur (primary and secondary hyperoxaluric syndromes). Current methods for determination of urinary oxalate usually involve isolation of oxalate from interfering substances by precipitation, extraction, or ion-exchange adsorption, followed by volumetric titration, spectrometry (UV/VIS absorption and fluorometric; atomic absorption spectroscopy) or gas or liquid chromatography. All these methods involving chromatographic and spectrophotometric detection are time consuming, and they lack sensitivity.
Therefore, enzymatic determinations with spectrometric or electrochemical detection are preferred because of their simplicity, speed, and higher sensitivity. Two enzymes are widely used in enzymatic methods for oxalate determination, i.e., oxalate decarboxylase and oxalate oxidase. The first enzyme catalyzes the decomposition of oxalate to formate and carbon dioxide, whereas oxalate oxidase, in the presence of oxygen, catalyzes the following reaction: 
From Equation 1, it is obvious that the concentration of oxalate can be determined indirectly, either by measuring the change in pH (which is proportional to the concentration of released CO 2 ), or by measuring the hydrogen peroxide concentration spectrophotometrically (1) (2) (3) (4) or electrochemically (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) ). An automated enzymatic method for the determination of urinary oxalate, resulting in the spectrophotometric determination of indamine dye, was proposed by Obzansky and Richardson (1) and Potezny et al. (2) . Determination with luminol by chemiluminescence detection of hydrogen peroxide released by the selective action of oxalate oxidase immobilized on silanized glass beads was suggested by Hansen et al. (3) . Inamdar et al. (4) proposed a simple method of entrapping oxalate oxidase and peroxidase in acrylamide and used an acrylamide membrane strip for spectroscopic determination of oxalate in urine.
Dinckaya and Telefoncu (5) reported an amperometric biosensor for oxalate determination based on immobilization of oxalate oxidase in gelatin by using glutaraldehyde on the top of the oxygen probe.
Winquist et al. (16) proposed an enzymatic thermistor biosensor for determination of oxalate with immobilized oxalate oxidase. This biosensor measures the heat that is evolved in an enzymatic reaction and which is proportional to the amount of substrate. They reported that oxalate can be directly measured in urine samples at oxalic acid concentrations of ≥0.2mM. The usual concentration range of human urinary oxalates is between 0.05 and 1mM; therefore, at oxalate concentrations of <0.2mM, an extraction step with tributyl phosphate was necessary to overcome the interference of other anions.
Reddy et al. (6) described an electrochemical biosensor for determination of human urinary oxalates. They co-immobilized oxalate oxidase in bovine serum albumin (BSA) by glutaraldehyde placed between hemodialysis and cellulose acetate membranes to prevent some chemical and electrochemical interferences. Saka et al. (7) prepared an oxalate biosensor by immobilizing oxalate oxidase on an activated collagen film. They also determined enzyme activity as a function of pH, ionic strength, and ambient chloride concentration.
To avoid both the interference of matrix constituents and oxygen influence on the current response of the biosensor, electron-mediated enzyme electrodes have been used. The most commonly used electron mediators include ferrocenes (8, 9) , ferricyanides (10, 11) , cobalt phtalocyanine (12) , and some others.
Despite extensive research into mediated/modified electrodes, the nonmediated peroxide-detecting system remains the most common operational form of amperometric enzyme electrodes.
Electrodes using direct amperometric determination of enzymatically produced hydrogen peroxide have been widely used in industrial, medical, and environmental research and for monitoring many biological reactions. In clinical applications, where the possible interferences in urine are homovanillic acid (13) , ascorbic acid (3), uric acid (14) , and many other compounds, high positive working electrode potentials have been avoided by electrocatalytic reduction of hydrogen peroxide on the surface of some hexacyanometallate-modified electrodes.
Milardovi et al. (15) designed an enzyme electrode that uses alkali hexacyanometallates, such as nickel(II) hexacyanferrate (NiHCF), for determination of enzymatically produced hydrogen peroxide to detect glucose in blood.
You Hin and Lowe (17) determined ethanol in urine by oxidation of reduced nicotinamide adenine dinucleotide on the surface of a NiHCF alcohol dehydrogenase-based biosensor.
Lin et al. (18) discussed the properties of chromium(III) hexacyanoferrate film for cathodic determination of hydrogen peroxide (18) , whereas Jiang et al. (19) investigated the properties of thin chromium(III) hexacyanoferrate films in potassium chloride and hydrochloride acid solutions.
The electrochemical behavior and preparation of chromium(III) hexacyanoferrate film were described by Gao (20) , and the immobilization of the enzyme on the surface of the CrHCF electrode for the determination of glucose was recently reported by Lin and Shih (21) .
Mas and Vallon (22) compared the performance of 2 biosensors; one with oxalate oxidase immobilized on a pre-activated nylon membrane, and the other with a collagen membrane after activation of the carboxyl groups by an acyl-azide reaction.
This paper describes the CrHCF-based biosensor for amperometric determination of oxalate in urine. Hydrogen peroxide is determined at a very low reduction potential (50 mV versus Hg | Hg 2 Cl 2 | 3M KCl reference electrode) to avoid interferences from ascorbic acid (usually present in the concentration range between 0.3 and 0.5mM) and uric acid. The buffer solution used was selected to obtain good current sensitivity and long-term stability of the biosensor. Determinations of oxalate in urine samples were made directly in batch mode without any sample pretreatment.
Experimental

Apparatus
All electrochemical experiments were performed with a polarographic analyzer Model 264A (EG&G, Princeton Applied Research, Princeton, NJ), interfaced to an IBM compatible personal computer for data acquisition and manipulation. A 3-electrode electrochemical cell having the electrochemical biosensor as the working electrode, Hg | Hg 2 Cl 2 | 3M KCl as the reference electrode, and a graphite rod as the auxiliary electrode was used. All electrochemical data were measured at 25°C in a 10 mL electrochemical cell. Samples were homogenized with an electromagnetic stirrer.
Reagents and Solutions
All chemicals used were analytical reagent grade. Oxalate oxidase (from barley seedlings, lyophilized powder, 0.71 units/mg solid), bovine serum albumin (BSA), and glutaraldehyde (mass fraction 25%) were obtained from Sigma (St. Louis, MO). Potassium hexacyanoferrate(III) trihydrate, succinic acid, oxalic acid dihydrate, hydrogen peroxide, chromium(III) nitrate nonahydrate, hydrochloric acid, potassium chloride, ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), L(+) ascorbic acid, uric acid, and potassium hydroxide were from Kemika (Zagreb, Croatia).
The supporting electrolyte was succinic buffer, pH 3.8, which contained 14mM succinic acid, 4mM potassium hydroxide, 0.1M potassium chloride, and 5.4mM EDTA.
The plating solution used to prepare the chromium(III) hexacyanoferrate(II) film consisted of 3.3mM potassium ferricyanide, 6.6mM chromium(III) nitrate nonahydrate, and 1M KCl. The solution was adjusted to pH 3.2 with 1M HCl.
Deionized water purified by a Millipore-MilliQ system was used in all experiments.
Electrode Preparation
A graphite rod of spectroscopic purity (4 or 5 mm in diameter and 5 mm long) was inserted into a polyvinyl chloride body and sealed with epoxy resin. Electric contact was made with copper wire, whereas the contact to graphite was made with a gold spring. The graphite disk was thoroughly rinsed in acetone, and then in deionized water, and air-dried. The graphite disk electrodes were pretreated electrochemically according to the procedure reported by Wang and Tuzhi (23) . A layer of chromium hexacyanoferrate was formed on the surface of each disk by potential cycling between 1.0 and -1.3 V at a scan rate of 100 mV/s in a chromium plating solution for 20 min, followed by 20 min of potential cycling between -0.2 and 0.9 V at the same scan rate.
Oxalate oxidase was immobilized by a glutaraldehyde-BSA cross-linking procedure on top of the potassium chromium(III) hexacyanoferrate(II) layer. A 1.0 mg portion of BSA was weighed into a specially designed vessel (volume, 30 µL), and 10 µL succinic buffer (pH 3.8) was added to obtain a mass fraction of ca 10%. A 0.2 mg portion (0.142 units) of oxalate oxidase was added to this solution. After 30 min, this albumin solution was mixed well with an equal volume of 2.5% (w/w) glutaraldehyde solution, and half of this mixture was deposited on top of the electrode. The electrode was left to dry for 20 min at room temperature to allow the formation of gel. The prepared enzyme electrode was conditioned overnight in succinic buffer solution (pH 3.8) at 6°C.
Urine Samples
Randomly collected urine samples were taken from the Clinical Hospital Center of Zagreb, Croatia. Samples were kept at -22°C until analysis. Urine samples with a low content of oxalate were chosen for further work. The biosensor was tested by determination of recoveries (amount added vs amount found) based on the addition of known concentrations of oxalic acid to samples of urine with a very low natural oxalate concentration (<1µM) as determined spectrophotometrically.
Results and Discussion
A cyclic voltammogram of the CrHCF electrode , obtained after 40 min of running cycles in plating solution to form the film of hexacyanoferrate, is shown in Figure 1 . Potentials were scanned between -200 and 1000 mV at a scan rate of 100 mV/s. The voltammogram shows 2 oxidation peaks at approximately 300 and 815 mV, and 2 reduction peaks at 680 and 130 mV, which indicate the formation of the mixed-valence compound of the general form KCr[Fe(CN) 6 ] in the film, as was previously described in the literature (18, 19) . The procedure of preparing KCrHCF in 2 steps offers better stability of the produced film than does a single-step procedure (18) .
The catalytic properties of chromium hexacyanoferrate were studied by cyclic voltammetry in succinic buffer solution, pH 3.8, containing 0.1M KCl in the potential range between -200 and 1000 mV at a scan rate of 50 mV/s (Figure 2 ). The increase in electrode response in the range between +150 and -200 mV after 4 successive additions of hydrogen peroxide (2, 4, 6, and 8mM) indicates the operating (working) electrocatalytic region of the CrHCF electrode.
The catalytic mechanisms of chromium hexacyanoferrate in hydrogen peroxide solution (21) can be described as follows: 
The potassium ions, or other alkali cations, enter or exit the crystal lattice of the complex anion [CrFe(CN) 6 ] 2-/-, depending on the chromium oxidation state, in order to keep the surface layer electroneutral, according to Equations 2 and 3. Therefore, the sensor can work properly only in the buffer solution containing alkali cations; otherwise, the redox reaction would not be possible. In the potential region between 0.00 and 0.05 V, the current sensitivity is highest and almost the same (the results of these measurements are not shown). In subsequent measurements, the working potential of 0.05 V was chosen.
The working potential of a biosensor for the determination of oxalate has to be slightly negative to prevent the possible oxidation of the most important interferences present in human urine (mainly ascorbic acid, uric acid, and some drugs). Cyclic voltammograms obtained at the CrHCF electrode in succinic buffer alone (Figure 3 , curve 1) and with the addition of 0.5mM ascorbic acid ( Figure 3 , curve 2) and 0.016mM uric acid ( Figure 3, curve 3 ) are practically identical within the potential range between -200 and 200mV. The results suggest that these possible interferences do not interfere at the concentration levels present in human urine samples (because of dilution of the real samples), even at a relatively high concentration of ascorbic acid (10mM) and uric acid (0.3mM).
The effect of pH on the response of the CrHCF-based oxalate biosensor in 100mM oxalate solutions is shown in Figure 4 . All measurements were made in succinic buffer containing 0.1M KCl and 5.4mM EDTA, at a working potential of 0.05 V. Current response was recorded in the pH range between 2.5 and 5.3. The highest current response observed at pH 3.8 correlates well with literature data (24) , meaning that the optimal pH for oxalate oxidase is between 3.6 and 3.8. The buffer solution contained EDTA to suppress the influence of enzyme inhibitors present in the samples of human urine (mainly divalent metal ions, such as Ba ). Therefore, succinate buffer, with EDTA having a pH of 3.8 was used in all subsequent investigations.
The steady-state amperometric calibration curve for the determination of oxalates in the samples of pure oxalic acid measured by the CrHCF-based oxalate biosensor is shown in Figure 5 . All experimental parameters were the same as those in the Figure 4 legend. The results show that the current response is linear in the oxalate concentration range between 2.5 and 100 µM.
The influence of urine sample dilution on biosensor response measured in succinic buffer (pH 3.8) containing 5.4mM EDTA and 0.1M KCl at 0.05 V is shown in Figure 6 . Some substances in urine can act as inhibitors or activators of oxalate oxidase (especially sodium chloride and/or divalent cations) and therefore can change the sensitivity of the biosensor. In extensive studies, Reddy et al. (6) found that this interference has to be minimized. This interference can be minimized by sample dilution (3). Investigation of the influence of sample dilution showed that the same biosensor current response is obtained for oxalate solution (30 µM) without urine ( oxalic acid, but with urine dilutions of 1:8 ( Figure 6 , response 3) and 1:5 ( Figure 6, response 4) , show a decrease in current values, indicating a lower biosensor response. This decreased response is due to the influence of the interference present in urine samples either through enzyme inhibition and/or insufficient cation sequestering for stoichiometric reasons. The biosensor response for the urine sample diluted 1:5 was only 50% of the initial value.
The concentrations of urinary oxalates are usually within a range of 0.05-1mM. Diluting the samples 1:20 decreases the oxalate concentration to a range of 2.5-50µM, where the biosensor shows good linear response and the influence of interferences is minimal.
During all measurements the solutions were stirred, and it was found that after 2 min, the sample was homogenized and a plateau in the current/time curve was obtained.
The stability of the biosensor was tested daily for >1 month. The electrode was kept in buffer solution at 6°C when not in use. After 25 days of testing, the sensitivity dropped from 5.6 to 3.5 nA/µM indicating that the half-life of the electrode was >1 month.
The good half-life of the biosensor and the relatively successful exclusion of interferences were the reasons why no attempt was made to use a membrane to prevent possible enzyme leaching or the selective exclusion of some interferences.
The correlation of results obtained by the addition of known concentrations of oxalic acid to urine samples (x-axis) with the concentrations (recoveries) of oxalic acid found in urine samples measured by the biosensor (y-axis) is shown in Figure 7 . All parameters were the same as those in the Figure 4 legend. Samples of urine (0.5 mL) were diluted with buffer solution, pH 3.8, in a volume ratio of 1:20, and known concentrations of oxalic acid (2.5-45µM) were added. Each point represents the mean of 3 separate measurements. A high correlation of results (R 2 = 0.9949) confirmed that the oxalate biosensor described in this paper can be successfully used for oxalate determinations in different matrixes (food samples, medical applications, environmental and process monitoring, etc.). The application of this biosensor to oxalate determinations in various food samples is in progress.
Conclusions
A biosensor for the determination of oxalate concentration was constructed. The graphite electrode (spectroscopic purity) was modified with chromium hexacyanoferrate, and on top of this film, oxalate oxidase was immobilized by using a well-known BSA-glutaraldehyde cross-linking procedure. This amperometric oxalate biosensor works at a low potential to reduce hydrogen peroxide (50 mV) in buffer solution (pH 3.8) containing succinic acid, EDTA as the enzyme activator, and potassium chloride as the inhibitor. The use of a mixed hexacyanoferrate as a catalytic surface for the reduction of hydrogen peroxide, produced by using the oxalate oxidase-catalyzed decomposition of oxalate in the presence of oxygen, appears to overcome the need to remove reductive agents in urine. These factors, in combination with a 1:20 dilution of urine samples, were sufficient to prevent electrochemical interference from 2 main constituents in urine samples and to avoid changes in ionic activity, which could influence enzymatic activity. As a result, the oxalate biosensor, which has demonstrated good sensitivity (2.5-100µM) and long stability (half-lifetime of the biosensor was >1 month), appears promising for clinical applications, analysis of food samples, environmental and process monitoring, and other uses. 
